The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for SSI Diagnostica sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
SSI Diagnostica is a medical equipment company that designs, manufactures, and distributes in-vitro diagnostic and microbiological devices. The company offers rapid test kits, sampling materials, culture test kits for urinary tract infections, PCR products, antigens, and bacterial strains. Its products are used in clinical and industrial microbiology, vaccine manufacturing, veterinary and dental clinics. SSI Diagnostica is headquartered in Hillerod, Hovedstaden, Denmark. Key subsidiaries of SSI Diagnostica include TECHLAB.
The key metrics of SSI Diagnostica related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As SSI Diagnostica is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as SSI Diagnostica.
For a detailed understanding of the performance of SSI Diagnostica, buy the report here.